Medical Device News Magazine

CATHI Joins with VSS to Launch World’s First Online Training Program for Endovascular Simulation

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

CATHI (Germany-based leading endovascular simulator supplier ) has joined forces with UK-based Vascular Simulation Solutions (VSS) to offer the world’s first on-line training masterclass using endovascular simulation coupled to a structured curriculum.

At its heart is the state-of-the-art CATHIS® simulator, which is fully functional with all standard software systems including every iOS system and Oculus VR (virtual reality).

The training is supported by a structured curriculum, delivered by specialist endovascular instructors with many years‘ clinical experience. The Program is targeted at specialist trainees in every year of their course, medical students (condensed course), and interested interventionists. The scope of the package includes EVAR for aneurysm repair, carotid, renal, iliac, femoral and tibial artery angioplasties. In addition, the curriculum includes training on emergency vascular cases such as ruptured aneurysms and visceral bleeding and trauma.

“The importance of periodical continuous education, training and structured curricula of interventional procedures has been confirmed by numerous clinical experts around the globe“, said CATHI Managing Director Marketing & Sales Manuela Werner. “With this joint venture between VSS and our company we are combining top level expertise with our near to reality simulation systems. We are very pleased to be cooperating with the very experienced vascular and endovascular surgeon Dr. Abdullah Jibawi.“

“We have built our curriculum with the end user in mind in every minute detail. We want to answer the real need for training by allowing a layer by layer build up of skills and decision making, associated with availability of performing procedure where and when the trainees feel so“, added Consultant Vascular Surgeon Dr Abdullah Jibawi. “Our program introduces the ability to train interventionists over a specified period of time, followed by a customised exposure to a specified product line to fine tune their experience as needed and required.“

The program is accredited by the Royal College of Surgeons of Edinburgh for Continuing professional development (CPD), valued at 12 CPD points.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”